Insider Transactions in Q3 2021 at Prelude Therapeutics Inc (PRLD)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2021
|
David J Mauro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-62.72%
|
$540,000
$36.87 P/Share
|
|
Sep 07
2021
|
David J Mauro Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.89 P/Share
|
|
Sep 02
2021
|
Christopher Pierce EVP and Chief of Business Oper |
SELL
Open market or private sale
|
Direct |
17,000
-39.88%
|
$697,000
$41.44 P/Share
|
|
Sep 02
2021
|
Christopher Pierce EVP and Chief of Business Oper |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+45.03%
|
$204,000
$12.85 P/Share
|
|
Aug 27
2021
|
Peggy Scherle Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,014
-1.13%
|
$216,504
$36.21 P/Share
|
|
Aug 27
2021
|
Peggy Scherle Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,014
+3.25%
|
$6,014
$1.43 P/Share
|
|
Aug 26
2021
|
Peggy Scherle Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,700
-0.97%
|
$59,500
$35.19 P/Share
|
|
Aug 26
2021
|
Peggy Scherle Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,700
+0.96%
|
$1,700
$1.43 P/Share
|
|
Aug 25
2021
|
Brian Piper Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,333
-62.53%
|
$274,989
$33.33 P/Share
|
|
Aug 25
2021
|
Brian Piper Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+50.0%
|
$8,333
$1.89 P/Share
|
|
Aug 13
2021
|
Peggy Scherle Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,286
-1.3%
|
$80,010
$35.07 P/Share
|
|
Aug 13
2021
|
Peggy Scherle Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,286
+0.65%
|
$2,286
$1.66 P/Share
|
|
Aug 05
2021
|
David J Mauro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-65.63%
|
$465,000
$31.44 P/Share
|
|
Aug 05
2021
|
David J Mauro Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.89 P/Share
|
|
Jul 27
2021
|
Peggy Scherle Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-5.2%
|
$700,000
$35.77 P/Share
|
|
Jul 27
2021
|
Peggy Scherle Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.39%
|
$20,000
$1.43 P/Share
|
|
Jul 06
2021
|
David J Mauro Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-87.68%
|
$420,000
$28.05 P/Share
|
|
Jul 06
2021
|
David J Mauro Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.89 P/Share
|